View videos that the Kore team has put together to learn
more about how the all-in-one platform will help your company
or broker-dealer better manage capital market activities.
Partners
General
Jeannette Spaulding, Dr. Kiran Garimella, and Oscar Jofre discuss what the capital markets are.
Douglas Ruark and Sara Hanks join Oscar Jofre to discuss the evolution of online capital formation.
Jeffrey Finkle from ArcView joins the KoreTalkX series to discuss perspectives on the cannabis industry.
Curtis Spears joins the KoreTalk X lineup to discuss the value of being industry agnostic in the private market.
Oscar Jofre, Dr. Kiran Garimella, and Richard Ring discuss what blockchain is to dispel confusion and misunderstandings on the topic.
In the final KoreSummit Empowering Growth session, speakers discuss ATS and digital securities for cannabis companies.
Industry experts discuss how companies should approach marketing for RegA+ and RegCF raises.
Learn more about what cannabis companies need to be aware of when preparing for a RegA or RegCF offering in the first session of the Emerging Growth KoreSummit.
Sara Hanks joins the KoreTalkX series to discuss important questions issuers may have about raising capital compliantly.
ArcView Capital's Brian MacDonald joins Rafael Goncalves to discuss the evolving cannabis industry and the private capital market.
Vincent Molinari and Rafael Goncalves discuss the evolution of the capital markets through streaming, blockchain, and ESG.
Rafael Goncalves and Samson Williams discuss Regulation CF and the Crowdfunding Professional Association in the most recent edition of KoreTalkX.
Rafael Gonçalves and Richard Heft discuss marketing strategies for companies looking to raise capital.
Nick Antaki from Reg D Resources joins Jason Futko to discuss compliance for Reg D, Reg A, and Reg CF offerings.
This panel wraps up the Medtech A+ Team event, giving a quick recap to the day's discussions.
In this panel, our speakers discuss secondary trading for Medtech companies.
In this panel, our speakers discuss the importance of investor acquisition and how issuers need a compelling story.